Intellia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	155.46	189.18	226.75	523.51	123.41
Short-Term Investments	294.42	412.33	685.48	669.12	625.28
Cash & Short-Term Investments	449.88	601.52	912.22	1,193	748.69
Cash Growth	-25.21%	-34.06%	-23.51%	59.29%	25.33%
Accounts Receivable	9.47	8.52	36.46	3.77	2.03
Other Current Assets	68.36	29.83	49.65	20.41	18.58
Total Current Assets	527.71	639.86	998.33	1,217	769.3
Net Property, Plant & Equipment	123.63	246.67	148.14	161	100.11
Long-Term Investments	155.25	260.22	111.63	101.79	395.49
Other Long-Term Assets	35.54	44.26	42.88	40.53	29.56
Total Assets	842.13	1,191	1,301	1,520	1,294
Accounts Payable	20.25	14.59	7.45	5.15	9.65
Accrued Expenses	49.86	55.36	67.02	60.88	43.31
Current Portion of Leases	26.48	20.25	18.6	16.69	9.11
Unearned Revenue	7.29	20.66	22.14	43.84	63.76
Total Current Liabilities	103.88	110.85	115.21	126.55	125.83
Long-Term Leases	66.85	189.95	96.75	114.02	64.91
Other Long-Term Liabilities	-	18.26	38.85	43.96	63.48
Total Long-Term Liabilities	66.85	208.21	135.6	157.98	-125.83
Total Liabilities	170.73	319.06	250.81	284.53	-
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	3,260	3,049	2,711	2,420	1,746
Accumulated Other Comprehensive Income	1.03	0.61	-2.26	-7.46	-2.63
Retained Earnings	-2,590	-2,177	-1,658	-1,177	-703
Shareholders' Equity	671.39	871.96	1,050	1,236	1,040
Total Liabilities & Equity	842.13	1,191	1,301	1,520	1,294
Total Debt	93.33	210.2	115.35	130.7	74.02
Net Cash (Debt)	356.56	391.32	796.88	1,062	674.67
Net Cash Growth	-8.88%	-50.89%	-24.96%	57.40%	20.89%
Net Cash Per Share	3.29	3.96	8.98	13.80	9.52
Book Value	671.39	871.96	1,050	1,236	1,040
Book Value Per Share	6.20	8.82	11.83	16.05	14.67
Tangible Book Value	671.39	871.96	1,050	1,236	1,040
Tangible Book Value Per Share	6.20	8.82	11.83	16.05	14.67

Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q